ASCO 2022 Conference Coverage
ASCO 2022 on Survival Update of Neoadjuvant Ipi + Nivo in Macroscopic Stage III Melanoma: The OpACIN and OpACIN-neo Trials
By
ASCO 2022 Conference Coverage
FEATURING
Judith Versluis
By
ASCO 2022 Conference Coverage
FEATURING
Judith Versluis
Login to view comments.
Click here to Login
